EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial

Miranda K Robinson, Euyhyun Lee, Patricia A Ugalde-Nicalo, Jaret W Skonieczny, Lauren F Chun, Kimberly P Newton, Jeffrey B Schwimmer

The Journal of Nutrition · 2024

DOI: 10.1016/j.tjnut.2024.07.030 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Nutrition, 2024. Verfasst von Miranda K Robinson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, C…. Hauptthemen laut MEDLINE: Dietary Supplements, Overweight, Obesity. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Obesity and its associated comorbidities are major public health concerns for which nutrition is central to disease prevention and management. Pentadecanoic acid (C15:0) has the potential for beneficial effects on obesity, but supplementation has not been studied in humans. OBJECTIVES: The primary objective was to investigate changes in plasma C15:0 levels after daily supplementation for 12 wk. Additionally, the study aimed to assess safety and tolerability as well as measure potential markers of physiologic response. METHODS: This was a single-center, double-blind, randomized, controlled, 2-arm trial of 200 mg C15:0 or placebo daily for 12 wk in young adults with overweight or obesity. RESULTS: A total of 30 participants with a mean age of 20.0 ± 2.1 y and a mean body mass index of 33.4 ± 5.3 kg/m2 were included. In total, 20 participants received C15:0 supplement and 10 received placebo. The mean increase in circulating C15:0 for the treatment group was 1.88 μg/mL greater than that of the placebo group (P = 0.003). No significant adverse events occurred. Half of the participants in the treatment group had a posttreatment C15:0 level >5 μg/mL. In these individuals, there were significantly greater decreases in alanine aminotransferase (-29 U/L, P = 0.001) and aspartate aminotransferase (-6 U/L, P = 0.014), as well as a greater increase in hemoglobin (0.60 g/dL, P = 0.010), as compared with participants that did not reach a posttreatment level >5 μg/mL. CONCLUSIONS: Daily C15:0 supplementation increased circulating C15:0 levels in young adults with overweight or obesity. End-of-treatment C15:0 >5 μg/mL was associated with potentially relevant improvements in clinical indices, warranting further study. This trial was registered at clinicaltrials.gov as NCT04947176.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsOverweightObesityHumansMaleFemaleDouble-Blind MethodYoung AdultFatty AcidsAdultBody Mass IndexAdolescent

Stichwörter der Autor:innen

aminotransferasesanemiafatty liverobesitypentadecanoic acid

Substanzen

pentadecanoic acidFatty Acids

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, United States.
  • Altman Clinical and Translational Research Institute, UC San Diego School of Medicine, University of California San Diego, La Jolla, CA, United States.
  • Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, United States; Department of Gastroenterology, Rady Children's Hosp…

Förderung

  • NCATS NIH HHS
  • NIH

Zitieren

APA

Robinson, M. K., Lee, E., Ugalde-Nicalo, P. A., Skonieczny, J. W., Chun, L. F., Newton, K. P., & Schwimmer, J. B. (2024). Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial. The Journal of Nutrition. https://doi.org/10.1016/j.tjnut.2024.07.030

Vancouver

Robinson MK, Lee E, Ugalde-Nicalo PA, Skonieczny JW, Chun LF, Newton KP, et al. Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial. The Journal of Nutrition. 2024. doi:10.1016/j.tjnut.2024.07.030

BibTeX
@article{Robinson2024,
  author = {Robinson, Miranda K and Lee, Euyhyun and Ugalde-Nicalo, Patricia A and Skonieczny, Jaret W and Chun, Lauren F and Newton, Kimberly P and Schwimmer, Jeffrey B},
  title = {Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial},
  journal = {The Journal of Nutrition},
  year = {2024},
  doi = {10.1016/j.tjnut.2024.07.030}
}
Kostenlos starten →